GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Price-to-Owner-Earnings

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Price-to-Owner-Earnings : (As of May. 30, 2024)


View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Price-to-Owner-Earnings?

As of today (2024-05-30), OWC Pharmaceutical Research's share price is $0.0001. OWC Pharmaceutical Research does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for OWC Pharmaceutical Research's Price-to-Owner-Earnings or its related term are showing as below:


OWCP's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.95
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-30), OWC Pharmaceutical Research's share price is $0.0001. OWC Pharmaceutical Research's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.07. Therefore, OWC Pharmaceutical Research's PE Ratio for today is At Loss.

As of today (2024-05-30), OWC Pharmaceutical Research's share price is $0.0001. OWC Pharmaceutical Research's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.08. Therefore, OWC Pharmaceutical Research's PE Ratio without NRI for today is At Loss.


OWC Pharmaceutical Research Price-to-Owner-Earnings Historical Data

The historical data trend for OWC Pharmaceutical Research's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Price-to-Owner-Earnings Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - - - - -

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 10.00 2.00

Competitive Comparison of OWC Pharmaceutical Research's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, OWC Pharmaceutical Research's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OWC Pharmaceutical Research's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OWC Pharmaceutical Research's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where OWC Pharmaceutical Research's Price-to-Owner-Earnings falls into.



OWC Pharmaceutical Research Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

OWC Pharmaceutical Research's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.0001/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OWC Pharmaceutical Research  (OTCPK:OWCP) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


OWC Pharmaceutical Research Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Traded in Other Exchanges
N/A
Address
2 Ben Gurion Street, Ramat Gan, ISR, 5257334
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.
Executives
Asher Zwebner director, officer: CHIEF FINANCIAL OFFICER CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Headlines